Shingles vaccine may boost survival in lung cancer patients

NCT ID NCT07170059

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times

Summary

This study looks at whether the shingles vaccine can prevent shingles and improve survival in 500 adults with lung cancer. Participants will be observed for 12 months to see who gets shingles and how long they live. The goal is to find out if this vaccine is safe and effective for people with lung cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

Explore the condition pages connected to this study.